Theseus Pharmaceuticals Alpha and Beta Analysis
| THRXDelisted Stock | USD 3.71 0.14 3.92% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Theseus Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Theseus Pharmaceuticals over a specified time horizon. Remember, high Theseus Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Theseus Pharmaceuticals' market risk premium analysis include:
Beta 1.14 | Alpha (0.69) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Theseus |
Theseus Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Theseus Pharmaceuticals market risk premium is the additional return an investor will receive from holding Theseus Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Theseus Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Theseus Pharmaceuticals' performance over market.| α | -0.69 | β | 1.14 |
Theseus Pharmaceuticals Fundamentals Vs Peers
Comparing Theseus Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Theseus Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Theseus Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Theseus Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Theseus Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Theseus Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Theseus Pharmaceuticals to competition |
| Fundamentals | Theseus Pharmaceuticals | Peer Average |
| Return On Equity | -0.26 | -0.31 |
| Return On Asset | -0.18 | -0.14 |
| Current Valuation | (20.19 M) | 16.62 B |
| Shares Outstanding | 44.65 M | 571.82 M |
| Shares Owned By Insiders | 2.55 % | 10.09 % |
| Shares Owned By Institutions | 93.28 % | 39.21 % |
| Number Of Shares Shorted | 401.68 K | 4.71 M |
Theseus Pharmaceuticals Opportunities
Theseus Pharmaceuticals Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | What is the Markets View on Theseus Pharmaceuticals Inc Stocks Price and Volume Trends Wednesday - InvestorsObserver | 06/07/2023 |
2 | Theseus Pharmaceuticals Inc is lower by 3.62 percent Monday In Premarket Trading - InvestorsObserver | 07/24/2023 |
About Theseus Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Theseus or other delisted stocks. Alpha measures the amount that position in Theseus Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Theseus Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Theseus Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Theseus Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Theseus Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Theseus Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Theseus Pharmaceuticals' management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Theseus Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |